Role of Alfuzosin in Ureteral Stent Related Urinary Symptoms Score: A Comparative Study
DOI:
https://doi.org/10.3126/jgmcn.v10i1.17912Keywords:
Alfuzosin, Alpha blocker, Ureteral stent, Urinary symptomsAbstract
Background: Ureteral stent placement is a routine urological procedure. However, patients inserted with ureteral stent exhibited increased urinary symptoms that compromise patients’ quality of life.
Objective: To assess the efficacy of alpha blockers (Alfuzosin) in the management of ureteral stent related urinary symptoms.
Methods: Total of 60 patients after ureteral stent insertion was randomly divided into two equal groups; 30 in alfuzosin group and the remaining 30 in control group. Urinary symptoms questionnaire was filled after two weeks and results were statistically analyzed.
Results: Urinary symptoms like urgency, frequency and flank pain were significantly less in the alfuzosin group when compared with control group.
Conclusion: Alpha blocker (Alfuzosin) was found to be effective in reducing ureteral stent related urinary symptoms.
Journal of Gandaki Medical College
Vol. 10, No. 1, 2017, page: 28-30
Downloads
Downloads
Published
How to Cite
Issue
Section
License
This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.